Investors

Home / Investors / Financials
v3.6.0.2
Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 10,495 $ 7,706
Marketable securities 6,499 33,774
Prepaid expenses 1,369 608
Other current assets 165 186
Total current assets 18,528 42,274
Property and equipment, net 77 64
Other assets 754 741
Total assets 19,359 43,079
Current liabilities:    
Accounts payable 899 1,008
Accrued liabilities 4,501 3,336
Warrant liability 1,145 1,220
Facility loan 2,700 509
Accrued interest payable 66 73
Total current liabilities 9,311 6,146
Facility loan, less current portion 6,098 8,799
Other liabilities 13 19
Total liabilities 15,422 14,964
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.0001 par value: 10,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.0001 par value: 100,000,000 shares authorized; 23,447,003 and 23,447,003 shares issued and outstanding as of December 31, 2016 and December 31, 2015, respectively 2 2
Additional paid-in capital 426,895 424,422
Accumulated other comprehensive loss (1) (21)
Accumulated deficit (422,959) (396,288)
Total stockholders' equity 3,937 28,115
Total liabilities and stockholders' equity $ 19,359 $ 43,079
v3.6.0.2
Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Operating expenses:    
Research and development $ 15,941 $ 17,026
General and administrative 9,645 8,871
Total operating expenses 25,586 25,897
Loss from operations (25,586) (25,897)
Other income (expense):    
Interest income 176 160
Interest expense (1,337) (913)
Other income, net 76 11,121
Net loss (26,671) (15,529)
Net loss (26,671) (15,529)
Other comprehensive income (loss):    
Unrealized gain (loss) on marketable securities 20 (7)
Other comprehensive income (loss) 20 (7)
Comprehensive loss $ (26,651) $ (15,536)
Basic net loss per common share $ (1.14) $ (0.82)
Diluted net loss per common share $ (1.14) $ (0.83)
Weighted average common shares outstanding used to calculate basic net loss per common share 23,447,003 18,900,473
Weighted average common shares outstanding used to calculate diluted net loss per common share 23,447,003 18,917,213
v3.6.0.2
Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Operating activities    
Net loss $ (26,671) $ (15,529)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 29 22
Stock-based compensation expense 2,473 2,487
Amortization of premium on marketable securities 125 511
Non-cash interest associated with debt discount accretion 476 228
Change in fair value of warrant liability (75) (11,121)
Changes in assets and liabilities:    
Other current assets 165 161
Prepaid expenses (761) 1,383
Other assets (13) (486)
Accounts payable (109) (1,077)
Accrued liabilities 1,015 (46)
Accrued interest payable (7) 143
Net cash used in operating activities (23,353) (23,324)
Investing activities    
Purchases of property and equipment (42)  
Purchases of marketable securities (22,906) (42,788)
Proceeds from maturities of marketable securities 50,076 31,705
Net cash provided by (used in) investing activities 27,128 (11,083)
Financing activities    
Proceeds from facility loan   9,482
Repayment of facility loan principal (986) (4,756)
Proceeds from issuance of common stock and warrants, net of issuance costs   25,375
Proceeds from issuance of common stock upon exercise of warrants   426
Net cash (used in) provided by financing activities (986) 30,527
Net increase (decrease) in cash and cash equivalents 2,789 (3,880)
Cash and cash equivalents at beginning of period 7,706 11,586
Cash and cash equivalents at end of period 10,495 7,706
Supplemental disclosure    
Cash paid for interest 866 535
Supplemental non-cash investing and financing activities    
Issuance of common stock warrants to lenders   258
Issuance of common stock upon warrant exercises   $ 1,513
Net change in accrued financing costs $ 144  
Financials Financials